Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas

Diagnostic Molecular Pathology

Volumn 6, Issue 6, 1997, Pages 333-341

  Pellín, Antonio ^c   Boix Ferrero, Javier ^c   Carpio, Dominica ^c   López Terrada, Dolores ^a   Carda, Carmen ^c   Navarro, Samuel ^c   Peydró Olaya, Amando ^c   Triche, Timoty J ^a   Llombart Bosch, Antonio ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

^c NONE

Author keywords

Amplification; Exon duplication; Exon loss; Immunohistochemistry; MDM2; Mutation; Osteosarcomas; Polymerase chain reaction; Polymorphism; RB1; Single strand conformational polymorphism; TP53

Indexed keywords

DNA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CHILD; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ADOLESCENT; ADULT; ANIMALS; BASE SEQUENCE; CHILD; FEMALE; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031421683     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199712000-00005     Document Type: Article

References (52)

1. Andreassen A, Øyjord T, Hovig E, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res 1993;53:468-71.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology. New York: Greene Publishing Associates and Wiley-Interscience, 1991.
3. Belchis DA, Meece CA, Benko FA, Rogan PK, Williams RA, Gocke CD. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas. Diagn Mol Pathol 1996;5:214-9.
4. Blanquet V, Turleau C, Gross MS, Goosens M, Besmond C. Identification of germline mutations in the RB1 gene by denaturant gradient gel electrophoresis and polymerase chain reaction direct sequencing. Hum Mol Genet 1993;2:975-9.
5. Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 1995;4:383-8.
6. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 1991; 51:6393-6.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
8. Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995;147: 545-60.
9. Cordon-Cardo C, Zhang ZF, Dalbagni G, et al. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 1997;57:1217-21.
10. Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL. Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 1989;9:4596-604.
11. Greenwald BD, Harpaz N, Yin J, et al. Loss of heterozigosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992;52: 741-5.
12. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994;172:1-4.
13. Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985;82:6216-20.
14. Hogg A, Onadim Z, Baird PN, Cowell JK. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. Oncogene 1992;7:1445-51.
15. Hollingswood RE, Lee WH. Tumor supressor genes: new prospects for cancer research. J Natl Cancer Inst 1991;83:91-6.
16. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 1996;24:141-6.
17. Horowitz JM, Yandell DW, Park SH, et al. Point mutational inactivation of the retinoblastoma antioncogene. Science 1989;243: 937-40.
18. Hurliman J, Chaubert P, Benhattar J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod Pathol 1994;7:423-8.
19. Huvos AG. Bone tumors. Diagnosis, treatment and prognosis. Philadelphia: WB Saunders, 1991.
20. Ito M, Mishima HK, Inai K, Ito T, Akiyama M. p53 and RB tumor suppressor gene alterations in retinoblastoma. International Journal of Oncology 1994;4:1329-32.
21. Jensen RD, Miller RW. Retinoblastoma: epidemiologic characteristics. New Engl J Med 1971;285:307-11.
22. Karpeh MS, Brennan MF, Cance WG, et al. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Br J Cancer 1995;72:985-91.
23. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.
24. Ladanyi M, Cha C, Lewis R, Jhanvar SC, Huvos AG, Healey JH. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993;53:16-8.
25. Lee EYP, To H, Shew JY, Bookstein R, Scully P, Lee WH. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988;241:218-21.
26. Lohman D, Horsthemke B, Gillessen-Kaesbach G, Stefani FH, Höfler H. Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis. Hum Genet 1992;89:49-52.
27. Lohman DR, Brandt B, Hopping W, Passarge E, Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 1996;58:940-9.
28. Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. p53 and MDM2 alterations in osteosarcomas. Correlation with clinicopathologic features and proliferative rate. Cancer 1997;79:1541-7.
29. López-Ginés C, Carda-Batalla C, López-Terrada L, Llombart-Bosch A. Presence of double minutes and monosomy 17p in xenografted human osteosarcomas. Cancer Genet Cytogenet 1996; 81:1-6.
30. Llombart Bosch A, Carda C, Peydró Olaya A, Noguera R, Pérez Bacete M, Pellín A, Boix J. Soft tissue Ewing's sarcoma. Characterization in established cultures and xenografts with evidence of a neuroectodermic phenotype. Cancer 1990;66:2589-601.
31. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 1987;84:7716-9.
32. Mazars GR, Jeanteur P, Lynch HT, Lenoir G, Theillet C. Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene. Oncogene 1992;7:781-2.
33. McGee TL, Yandel DW, Dryja TP. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene 1989;80:119-28.
34. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996;122:559-65.
35. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991;51:5520-5.
36. Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS. MDM2 gene amplification in bone and soft tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer (Pred Oncol) 1995;64:342-6.
37. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
38. Park SH. PCR in the diagnosis of retinoblastoma. In: MA Innis, DH Gelfand, JJ Sninsky, TJ White, eds. PCR protocols. A guide to methods and applications. London: Academic Press, 1990:407-15.
39. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory, 1989.
40. Scholz RB, Kabish H, Weber B, Röser K, Delling G, Winkler K. Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 1992;9:125-37.
41. Schulz A, Jundt G, Berghäuser KH, Gehron-Robey P, Termine D. Immunohistochemical study of osteonectin in various types of osteosarcoma. Am J Pathol 1988;132:233-8.
42. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
43. Spinardi L, Mazars R, Theillet C. Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res 1991;19: 4009.
44. Tarkkanen M, Karhu R, Kallioniemi A, et al. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1995;55:1334-8.
45. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988;48: 3939-43.
46. Toguchida J, Ishizaki K, Nakamura Y. Assignment of common allele loss in osteosarcoma to the subregion 17p13. Cancer Res 1989;49:6247-51.
47. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992; 52:6194-9.
48. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 1993;68: 1134-9.
49. Wadayama B, Toguchida J, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T. Mutation spectrum of the retinoblastoma gene in osteosarcoma. Cancer Res 1994;54:3042-8.
50. Weir-Thompson E, Condie A, Leonard RCF, Prosser J. A familial RB1 mutation detected by the HOT technique is homozigous in a second primary neoplasm. Oncogene 1991;6:2353-6.
51. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994;7:480-4.
52. Yamaguchi T, Toguchida J, Yamamuro T, et al. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 1992;52:2419-23.